{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:43:53Z","timestamp":1777725833343,"version":"3.51.4"},"reference-count":34,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1507\/endocrj.ej12-0308","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T23:04:20Z","timestamp":1353539060000},"page":"337-346","source":"Crossref","is-referenced-by-count":22,"title":["Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine, two sedatives frequently used in clinical settings"],"prefix":"10.1507","volume":"60","author":[{"given":"Shiho","family":"Yamato Kodera","sequence":"first","affiliation":[{"name":"Division of Anesthesiology, Second Department of General Medicine, Saitama Medical Center, Jichi Medical University School of Medicine, Omiya 330-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Complementary Medicine, First Department of General Medicine, Saitama Medical Center, Jichi Medical University School of Medicine, Omiya 330-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Dezaki","sequence":"additional","affiliation":[{"name":"Department of Intergrated Physiology, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Yada","sequence":"additional","affiliation":[{"name":"Department of Intergrated Physiology, Jichi Medical University School of Medicine, Shimotsuke 329-0498, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Murayama","sequence":"additional","affiliation":[{"name":"Division of Anesthesiology, Second Department of General Medicine, Saitama Medical Center, Jichi Medical University School of Medicine, Omiya 330-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Nerima Hikarigaoka Hospital, Tokyo 179-0072, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kakei","sequence":"additional","affiliation":[{"name":"Division of Complementary Medicine, First Department of General Medicine, Saitama Medical Center, Jichi Medical University School of Medicine, Omiya 330-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tan JA, Ho KM (2010) Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. <i>Intensive Care Med<\/i> 36: 926-939.","DOI":"10.1007\/s00134-010-1877-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Walker J, Maccallum M, Fischer C, Kopcha R, Saylors R, et al. (2006) Sedation using dexmedetomidine in pediatric burn patients. <i>J Burn Care Res<\/i> 27: 206-210.","DOI":"10.1097\/01.BCR.0000200910.76019.CF"},{"key":"3","unstructured":"3. Ambrisko TD, Hikasa Y (2003) The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs. <i>Can J Vet Res<\/i> 67: 64-67."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nishimura R, Kim HY, Matsunaga S, Hayashi K, Tamura H, et al. (1994) Effects of medetomidine-midazolam on plasma glucose and insulin concentrations in laboratory pigs. <i>J Vet Med Sci<\/i> 56: 559-561.","DOI":"10.1292\/jvms.56.559"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rorsman P, Bokvist K, Ammala C, Arkhammar P, Berggren PO, et al. (1991) Activation by adrenaline of a low-conductance G protein-dependent K+ channel in mouse pancreatic B cells. <i>Nature<\/i> 349: 77-79.","DOI":"10.1038\/349077a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sieg A, Su J, Munoz A, Buchenau M, Nakazaki M, et al. (2004) Epinephrine-induced hyperpolarization of islet cells without KATP channels. <i>Am J Physiol Endocrinol Metab<\/i> 286: E463-471.","DOI":"10.1152\/ajpendo.00365.2003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mason KP, Lerman J (2011) Review article: Dexmedetomidine in children: current knowledge and future applications. <i>Anesth Analg<\/i> 113: 1129-1142.","DOI":"10.1213\/ANE.0b013e31822b8629"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Benson GJ, Grubb TL, Neff-Davis C, Olson WA, Thurmon JC, et al. (2000) Perioperative stress response in the dog: effect of pre-emptive administration of medetomidine. <i>Vet Surg<\/i> 29: 85-91.","DOI":"10.1111\/j.1532-950X.2000.00085.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Murrell JC, Hellebrekers LJ (2005) Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog. <i>Vet Anaesth Analg<\/i> 32: 117-127.","DOI":"10.1111\/j.1467-2995.2005.00233.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakazaki M, Kakei M, Koriyama N, Tanaka H (1995) Involvement of ATP-sensitive K+ channels in free radical-mediated inhibition of insulin secretion in rat pancreatic beta-cells. <i>Diabetes<\/i> 44: 878-883.","DOI":"10.2337\/diab.44.8.878"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Dezaki K, Damdindorj B, Sone H, Dyachok O, Tengholm A, et al. (2011) Ghrelin Attenuates cAMP-PKA Signaling to Evoke Insulinostatic Cascade in Islet &beta;-Cells. <i>Diabetes<\/i> 60: 2315-2324.","DOI":"10.2337\/db11-0368"},{"key":"12","unstructured":"12. Yang SN, Berggren PO (2005) Beta-cell CaV channel regulation in physiology and pathophysiology. <i>Am J Physiol Endocrinol Metab<\/i> 288: E16-28."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vignali S, Leiss V, Karl R, Hofmann F, Welling A (2006) Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells. <i>J Physiol<\/i> 572: 691-706.","DOI":"10.1113\/jphysiol.2005.102368"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. <i>Anesthesiology<\/i> 93: 382-394.","DOI":"10.1097\/00000542-200008000-00016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yamazaki S, Katada T, Ui M (1982) Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets. <i>Mol Pharmacol<\/i> 21: 648-653.","DOI":"10.1016\/S0026-895X(25)14914-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Schermerhorn T, Sharp GW (2000) Norepinephrine acts on the KATP channel and produces different effects on [Ca2+]i in oscillating and non-oscillating HIT-T15 cells. <i>Cell Calcium<\/i> 27: 163-173.","DOI":"10.1054\/ceca.2000.0107"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Holz GG, Heart E, Leech CA (2008) Synchronizing Ca2+ and cAMP oscillations in pancreatic beta-cells: a role for glucose metabolism and GLP-1 receptors? Focus on &ldquo;regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach&rdquo;. <i>Am J Physiol Cell Physiol <\/i>294: C4-6.","DOI":"10.1152\/ajpcell.00522.2007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gromada J, Brock B, Schmitz O, Rorsman P (2004) Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential. <i>Basic Clin Pharmacol Toxicol<\/i> 95: 252-262.","DOI":"10.1111\/j.1742-7843.2004.t01-1-pto950502.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ammala C, Ashcroft FM, Rorsman P (1993) Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. <i>Nature<\/i> 363: 356-358.","DOI":"10.1038\/363356a0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Leech CA, Dzhura I, Chepurny OG, Schwede F, Genieser HG, et al. (2010) Facilitation of ss-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac. <i>Islets<\/i> 2: 72-81.","DOI":"10.4161\/isl.2.2.10582"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Seino S, Shibasaki T (2005) PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. <i>Physiol Rev<\/i> 85: 1303-1342.","DOI":"10.1152\/physrev.00001.2005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Peterhoff M, Sieg A, Brede M, Chao CM, Hein L, et al. (2003) Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice. <i>Eur J Endocrinol<\/i> 149: 343-350.","DOI":"10.1530\/eje.0.1490343"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zhao Y, Fang Q, Straub SG, Sharp GW (2008) Both G i and G o heterotrimeric G proteins are required to exert the full effect of norepinephrine on the beta-cell K ATP channel. <i>J Biol Chem<\/i> 283: 5306-5316.","DOI":"10.1074\/jbc.M707695200"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gentili F, Pigini M, Piergentili A, Giannella M (2007) Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes. <i>Curr Top Med Chem<\/i> 7: 163-186.","DOI":"10.2174\/156802607779318235"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yoshida M, Nakata M, Yamato S, Dezaki K, Sugawara H, et al. (2010) Voltage-dependent metabolic regulation of Kv2.1 channels in pancreatic beta-cells. <i>Biochem Biophys Res Commun<\/i> 396: 304-309.","DOI":"10.1016\/j.bbrc.2010.04.088"},{"key":"26","unstructured":"26. Jacobson DA, Philipson LH (2007) Action potentials and insulin secretion: new insights into the role of Kv channels. <i>Diabetes Obes Metab<\/i> 9 Suppl 2: 89-98."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoshida M, Dezaki K, Yamato S, Aoki A, Sugawara H, et al. (2009) Regulation of voltage-gated K+ channels by glucose metabolism in pancreatic beta-cells. <i>FEBS Lett<\/i> 583: 2225-2230.","DOI":"10.1016\/j.febslet.2009.05.050"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yan L, Figueroa DJ, Austin CP, Liu Y, Bugianesi RM, et al. (2004) Expression of voltage-gated potassium channels in human and rhesus pancreatic islets. <i>Diabetes<\/i> 53: 597-607.","DOI":"10.2337\/diabetes.53.3.597"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. MacDonald PE, Wheeler MB (2003) Voltage-dependent K+ channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. <i>Diabetologia<\/i> 46: 1046-1062.","DOI":"10.1007\/s00125-003-1159-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Misonou H, Thompson SM, Cai X (2008) Dynamic regulation of the Kv2.1 voltage-gated potassium channel during brain ischemia through neuroglial interaction. <i>J Neurosci<\/i> 28: 8529-8538.","DOI":"10.1523\/JNEUROSCI.1417-08.2008"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Park KS, Mohapatra DP, Misonou H, Trimmer JS (2006) Graded regulation of the Kv2.1 potassium channel by variable phosphorylation. <i>Science<\/i> 313: 976-979.","DOI":"10.1126\/science.1124254"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ullrich S, Wollheim CB (1988) GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels. <i>J Biol Chem<\/i> 263: 8615-8620.","DOI":"10.1016\/S0021-9258(18)68349-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Renstrom E, Ding WG, Bokvist K, Rorsman P (1996) Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin. <i>Neuron<\/i> 17: 513-522.","DOI":"10.1016\/S0896-6273(00)80183-X"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sharp GW, Le Marchand-Brustel Y, Yada T, Russo LL, Bliss CR, et al. (1989) Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. <i>J Biol Chem<\/i> 264: 7302-7309.","DOI":"10.1016\/S0021-9258(18)83234-3"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/3\/60_EJ12-0308\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:35:51Z","timestamp":1745228151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/3\/60_EJ12-0308\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0308","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}